ANCA-Negative Relapses in Patients with ANCA-Associated Vasculitis (KIDNEY WEEK 2026) - Oct 2, 2026 - Abstract #FR-PO0656; Pres time: Oct 23, 2026; 10:00 AM - 12:00 PM; Location: Exhibit Hall A, Convention Center; "2 were subsequently well controlled on avacopan, 2 others on methotrexate monotherapy. 4 others were controlled with rituximab, and/or MMF 1, AZA 1 and minimal prednisone 2...Patients appear to respond well to modest increases in immunosuppression. These findings suggest that there may be additional, non-ANCA, drivers of GPA disease activity."
Clinical • ANCA Vasculitis • Inflammation • Ocular Inflammation • Ophthalmology • Otorhinolaryngology • Scleritis • Vasculitis
|
|
Sydney Aaron; Orhan Efe; Ayman Al Jurdi; Harish Shanthanu Seethapathy; Ashima Chadha; James L. Chung; Karen A. Laliberte; John L. Niles
|